Le, Phuc

Early‐ and later‐stage persistence with antiobesity medications: A retrospective cohort study

Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., & Rothberg, M. B. (2024) · Obesity

Pharmacology and Obesity TreatmentMedication Adherence and Compliance

Cited by 94

One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice

Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., Butsch, W. S., & Rothberg, M. B. (2024) · JAMA Network Open

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 71

Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status

Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., Boyer, C. B., Griebeler, M. L., Burguera, B., & Rothberg, M. B. (2025) · Obesity

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 54

Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills

Gasoyan, H., Pfoh, E. R., Schulte, R., Sullivan, E., Le, P., & Rothberg, M. B. (2024) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 41

Adherence to the American Diabetes Association’s glycemic goals in the treatment of diabetes among older americans, 2001-2018

Le, P., Ayers, G., Misra-Hebert, A. D., Herzig, S. J., Herman, W. H., Shaker, V. A., & Rothberg, M. B. (2022) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 26